Private Equity in Healthcare: Market Trends, Evidence-Based Impacts, and the Path Forward

Healthcare continues to demonstrate exceptional strength as a private equity (PE) investment sector, with the recently released Bain Co.'s 2026 Global Healthcare Private Equity Report documenting remarkable growth: global healthcare deal value reached $191 billion in 2025, surpassing the previous 2021 peak, with more than 30 megadeals exceeding $1 billion (compared to only 8 in 2024). Exit value reached $156 billion in 2025, up from $54 billion in 2024, demonstrating that PE funds have successfully resumed selling assets to other funds after the 2023-2024 slowdown.

Current Investment Landscape and Opportunities

The hottest subsectors for PE investment (2025-2026) include:

• Healthcare IT (revenue cycle management, analytics, AI)

• Physician services platforms (dermatology, gastroenterology, ophthalmology, orthopedics, behavioral health)

• Biopharma services

• Medtech (high-tech, minimally invasive devices)

• Physician/APP support services

For years, PE pursued a buy-and-build strategy, acquiring fragmented practices and consolidating them into larger entities to achieve scale. While this approach continues, Bain Co. concluded that this simple strategy is no longer sufficient for sustained success, driving increased diversification and sophistication in investment approaches.

Within physician services platforms, "outsourced" physician services attract substantial capital: clinical staffing companies, anesthesia, emergency medicine, laboratory and imaging services. A major emerging theme—"Derivative Provider Services"—reflects investors shifting toward businesses that sell services to providers rather than directly owning providers themselves. This includes healthcare staffing companies, supply chain and distribution, revenue integrity/documentation/coding services, patient engagement platforms, and practice management solutions. Interest in acquiring hospitals and hospital systems has declined.

PE firms are increasingly focusing on operational value creation, emphasizing operational improvement and technology enablement over pure financial engineering. However, several headwinds persist: regulatory scrutiny from the Department of Justice, Federal Trade Commission, and Department of Health and Human Services; geopolitical trade issues; and volatile interest rates.

The Strategic Imperative: Why PE Firms Need Clinical Operations Executives

The healthcare sector differs fundamentally from other industries in ways that create both exceptional opportunities and unique risks for PE investors. Understanding these differences—and building the right leadership team to navigate them—represents the difference between sustainable value creation and value destruction.

The Capital Opportunity in Healthcare

Traditional healthcare organizations face severe financial constraints that create genuine opportunities for PE capital deployment. A mid-size nonprofit regional health system with $7 billion in annual gross revenue and 2.1% net operating income (the 2024 median) generates only $147 million annually for reinvestment across infinite competing priorities: aging facilities, technology infrastructure, physician recruitment, service line expansion, and quality improvement initiatives.

PE capital can fund transformative investments that struggling independent practices and health systems cannot afford: new facilities and ambulatory centers, marketing and referral networks, technology innovation, centralized administrative functions, electronic health record optimization, and value-based care infrastructure. These investments create genuine value when deployed strategically with clinical and operational expertise.

The Physician Leadership Advantage

Research demonstrates that physician involvement in healthcare leadership and governance is associated with superior organizational performance. A systematic review examining medical leadership found that hospitals and healthcare organizations with physician leaders on governing boards and in management positions demonstrate better performance across multiple domains. Specifically, physician leadership is associated with improved quality outcomes, enhanced organizational culture, more effective quality improvement initiatives, and stronger leadership pipelines.

For PE firms, this evidence suggests that partnering with experienced clinical operations leaders early in the acquisition process—not as an afterthought—can directly enhance the financial and operational performance that drives returns. Physician executives bring irreplaceable expertise in care model assessment, clinical workflow optimization, physician engagement strategies, and quality-centered performance improvement.

The Operations Excellence Imperative

While PE firms excel at financial structuring, capital deployment, and strategic growth, clinical leadership and healthcare operations require specialized expertise that differs fundamentally from other sectors. The viability and ultimate success of a healthcare business are determined by the care model—the clinical workflows, staffing patterns, technology infrastructure, and patient experience design that deliver care.

When considering healthcare investments, PE firms should assess the soundness of the care model with the same rigor applied to EBITDA growth projections and exit valuations. Critical questions include: Is the current care model sustainable and suited for growth? What are the staffing requirements to maintain quality and safety? How do clinical workflows impact efficiency and patient satisfaction? What technology investments are necessary versus optional? How does the care model perform under value-based payment models?

Addressing the Physician-PE Relationship Challenge

Research confirms that physicians hold concerns about PE involvement in healthcare, with worries clustering around: loss of individual autonomy in daily work and decision-making, impact on quality of care, work-life balance considerations, PE investment strategies and timelines, and perceived lack of medical versus managerial expertise among PE leadership.

This philosophical tension is real: physicians traditionally view healthcare through a professional service model emphasizing autonomy, long-term patient outcomes, and professional ethics, while PE operates on a financial return model prioritizing growth, operational efficiency, and exit valuation within 3-7 years.

However, this tension can be transformed into strategic alignment when PE firms engage physicians and clinical operations leaders upstream in the investment process. Interviews with physicians regarding PE acquisitions reveal that acquisition can be an attractive option, particularly when physicians see opportunities for: capital investment in facilities and technology they could not otherwise afford, relief from administrative burdens through centralized functions, access to sophisticated management expertise, and participation in governance and strategic decision-making.

The Evidence-Based Case for Quality-Centered Performance

High-quality, patient-centered care is not merely an ethical imperative—it is a financial imperative in competitive healthcare markets. Research demonstrates that patient experience is strongly associated with clinical outcomes, safety metrics, and patient loyalty. Organizations with superior patient experience demonstrate lower readmission rates, fewer adverse events, higher patient retention, and stronger market reputation.

For PE firms, this means that quality metrics should be weighted equally with financial metrics in performance evaluation and management incentive structures. The Quadruple Aim framework—better quality of care, better patient experience, higher team member engagement, all at lower cost—provides an evidence-based roadmap for sustainable value creation.

Studies examining PE acquisition of healthcare organizations have documented concerning patterns when quality is not prioritized: increased hospital-acquired adverse events, worsened patient experience scores, increased physician turnover (265% increase in one study), and reduced staffing levels. These outcomes not only harm patients but also undermine long-term financial performance through reputation damage, regulatory scrutiny, and workforce instability.

Conversely, PE firms that partner with physician and operations executives to implement quality-centered strategies can achieve both clinical and financial excellence. This requires: establishing quality and safety metrics as primary performance indicators alongside financial metrics, investing in adequate staffing levels and skill mix to maintain care standards, engaging physicians in governance and operational decision-making, implementing technology to support rather than burden clinical workflows, and aligning management incentives with both quality and financial outcomes.

The Strategic Partnership Model: Recommendations for PE Firms

To maximize returns while building sustainable, high-performing healthcare organizations, PE firms should adopt the following strategies:

1. Upstream Clinical Operations Engagement : Engage experienced physician executives during due diligence and pre-acquisition planning, not after the transaction closes. Physician executives should participate in: care model assessment and sustainability analysis, physician culture and engagement evaluation, quality and safety infrastructure review, clinical operations optimization planning, and post-acquisition integration strategy. This upstream engagement allows PE firms to identify operational risks and opportunities that financial due diligence cannot reveal, build credibility with the physician workforce from day one, and design integration plans that preserve clinical excellence while achieving efficiency gains

2. Quality-Centered Performance Metrics: Implement balanced scorecards that weight quality, safety, patient experience, and workforce engagement equally with financial metrics. Management incentive compensation should reflect this balance, rewarding leaders who achieve financial targets while maintaining or improving quality outcomes.

3. Care Model Due Diligence: Before acquisition, conduct rigorous care model assessment parallel to financial due diligence. This assessment should evaluate: clinical workflow efficiency and bottlenecks, staffing adequacy and skill mix, technology infrastructure and optimization opportunities, patient access and experience design, quality and safety performance relative to benchmarks, and sustainability under value-based payment models. Physician and clinical operations leaders should lead this assessment, providing PE investment committees with clear analysis of care model strengths, risks, and improvement opportunities.

4. Transparent Governance and Physician Engagement: Establish governance structures that include physician representation and create transparent communication channels between PE ownership, management, and clinical staff. This includes: physician representation on advisory boards or governing committees, regular town halls and communication forums, physician involvement in strategic planning and service line decisions, and transparent sharing of financial and quality performance data. Research demonstrates that physician engagement in governance and management is associated with superior organizational performance, making this not just good ethics but sound business strategy.

5. Long-Term Value Creation Focus: While PE investment timelines typically span 3-7 years, healthcare transformation requires realistic timelines that account for clinical complexity, regulatory requirements, and workforce culture change. PE firms should: set realistic timelines for operational improvements that account for healthcare's complexity, invest in infrastructure and technology with multi-year payback periods, build sustainable care models that will attract buyers at exit, and avoid short-term cost-cutting that undermines long-term value.

The Competitive Advantage of Physician-Operations-PE Partnership

PE firms that successfully partner with physician executives and operations executives gain significant competitive advantages:

• Enhanced Due Diligence: Physician and operations executives identify risks and opportunities that financial analysis alone cannot reveal, leading to better investment decisions and more accurate valuations.

• Faster Integration: Upstream physician engagement builds credibility and trust, accelerating post-acquisition integration and reducing physician turnover and patient attrition.

• Operational Excellence: Implement evidence-based improvements to clinical workflows, staffing models, and technology infrastructure that drive both quality and efficiency gains.

• Quality-Driven Growth: Organizations that maintain or improve quality while achieving efficiency gains attract more patients, command higher reimbursement rates, and build stronger market positions.

• Regulatory Resilience: Quality-centered operations reduce regulatory risk and position organizations favorably as scrutiny of PE healthcare investments increases.

• Superior Exit Valuations: Healthcare organizations with strong quality metrics, engaged physician workforces, and sustainable care models command premium valuations at exit.

The Path to Sustainable Healthcare PE Investment

Private equity investment in healthcare will continue given strong market fundamentals and genuine capital needs across the sector. The opportunity for value creation is substantial, but realizing this opportunity requires PE firms to fundamentally reimagine their approach to healthcare investments.

The evidence is clear: physician leadership improves healthcare organizational performance, quality-centered operations drive both clinical and financial excellence, and sustainable value creation requires deep expertise in care model design and clinical operations. PE firms that partner with experienced physician executives and operations executives—engaging them upstream in due diligence, integration planning, and ongoing management—will outperform competitors who rely heavily on financial engineering. This aligns the financial return objectives of PE investors with the clinical excellence priorities of physicians and the operational sustainability requirements of healthcare organizations. It transforms the philosophical tension between financial and clinical models into strategic synergy, creating organizations that deliver superior returns while improving patient care.

Vantage Clinical Partners, where Clinical Insights Meet Operational Excellence, can help PE firms navigate this complex landscape and build the physician-operations-investor partnerships that drive sustainable success in healthcare.

Val Akopov, MD MBA MHA

Principal & Chief Clinical Officer

1. Linking Leadership Development Programs for Physicians With Organization-Level Outcomes: A Realist Review. BMC Health Services Research. 2023. Debets M, Jansen I, Lombarts K, et al.

2. Medical Leadership: Boon or Barrier to Organisational Performance? A Thematic Synthesis of the Literature. BMJ Open. 2020. Savage M, Savage C, Brommels M, Mazzocato P.

3. Clinical Leadership and Hospital Performance: Assessing the Evidence Base. BMC Health Services Research. 2016. Sarto F, Veronesi G.

4. Medical Leadership, a Systematic Narrative Review: Do Hospitals and Healthcare Organisations Perform Better When Led by Doctors?. BMJ Open. 2017. Clay-Williams R, Ludlow K, Testa L, Li Z, Braithwaite J.

5. Evidence-Based Leadership Development for Physicians: A Systematic Literature Review.

Social Science & Medicine. 2020. Geerts JM, Goodall AH, Agius S.

6. Physician Turnover Increased in Private Equity-Acquired Physician Practices. Health Affairs. 2025. Singh Y, Cardenas GB, Torabzadeh H, Borkar D, Whaley CM.